Department of Primary Care and Public Health, Imperial College, St. Dunstan's Road, London, United Kingdom.
Ann Fam Med. 2012 May-Jun;10(3):228-34. doi: 10.1370/afm.1335.
We wanted to examine the long-term effects of the Quality and Outcomes Framework (QOF), a major pay-for-performance program in the United Kingdom, on ethnic disparities in diabetes outcomes.
We undertook an interrupted time series analysis of electronic medical record data of diabetes patients registered with 29 family practices in South West London, United Kingdom. Main outcome measures were mean hemoglobin A(1c) (HbA(1c)), total cholesterol, and blood pressure.
The introduction of QOF was associated with initial accelerated improvements in systolic blood pressure in white and black patients, but these improvements were sustained only in black patients (annual decrease: -1.68 mm Hg; 95% CI, -2.41 to -0.95 mm Hg). Initial improvements in diastolic blood pressure in white patients (-1.01 mm Hg; 95% CI, -1.79 to -0.24 mm Hg) and in cholesterol in white (-0.13 mmol/L; 95% CI, -0.21 to -0.05 mmol/L) and black (-0.10 mmol/L; 95% CI, -0.20 to -0.01 mmol/L) patients were not sustained in the post-QOF period. There was no beneficial impact of QOF on HbA(1c) in any ethnic group. Existing disparities in risk factor control remained largely intact (for example; mean HbA(1c): white 7.5%, black 7.8%, south Asian 7.8%; P <.05) at the end of the study period.
A universal pay-for-performance scheme did not appear to address important disparities in chronic disease management over time. Targeted quality improvement strategies may be required to improve health care in vulnerable populations.
我们旨在研究英国主要的按绩效付费计划——质量和结果框架(QOF)对糖尿病治疗结果的种族差异的长期影响。
我们对英国伦敦西南部 29 家家庭诊所注册的糖尿病患者的电子病历数据进行了中断时间序列分析。主要观察指标为平均糖化血红蛋白(HbA1c)、总胆固醇和血压。
QOF 的引入与白人和黑人患者的收缩压初始加速改善相关,但这些改善仅在黑人患者中持续(年降幅:-1.68mmHg;95%CI,-2.41 至-0.95mmHg)。白人患者的舒张压初始改善(-1.01mmHg;95%CI,-1.79 至-0.24mmHg)和白人患者的胆固醇初始改善(-0.13mmol/L;95%CI,-0.21 至-0.05mmol/L)和黑人患者的胆固醇初始改善(-0.10mmol/L;95%CI,-0.20 至-0.01mmol/L)在 QOF 后期间并未持续。QOF 对任何种族组的 HbA1c 均无有益影响。在研究期末,风险因素控制方面的现有差异仍然基本保持不变(例如,HbA1c 平均值:白人 7.5%,黑人 7.8%,南亚裔 7.8%;P<0.05)。
普遍的按绩效付费计划似乎并没有随着时间的推移解决慢性疾病管理方面的重要差异。可能需要有针对性的质量改进策略来改善弱势群体的医疗保健。